1. Nemet AY. The etiology of epiphora: a multifactorial issue. Semin Ophthalmol. 2016;31(3):275-279. doi:10.3109/08820538.2014.962163
2. Koh S, Ochi S, Inoue Y. Lacrimal drainage function after cheese wiring of lacrimal passage intubation. Graefes Arch Clin Exp Ophthalmol. 2020; 258(5):1087-1093. doi:10.1007/s00417-020-04612-z
3. Pflugfelder SC, Stern ME. Biological functions of tear film. Exp Eye Res. 2020;197:108115. doi:10.1016/j.exer.2020.108115
4. Akaishi PS, Schellini SA. Diagnosing and treating epiphora in the 21st century. Arq Bras Oftalmol. 2024;87(5):e2024-0099. doi:10.5935/0004-2749.2024-0099
5. Warees A, Saeed A, Hasan W, Ahsan S, Faraz M. Precision gene therapy: a transformative approach to treat age-related macular degeneration (ARMD). Ophthalmol Res Int J. 2025;20(4):1-15. doi:10.9734/or/2025/v20i4461
6. Avdagic E, Phelps PO. Nasolacrimal duct obstruction as an important cause of epiphora. Dis Month. 2020;66(10):101043. doi:10.1016/j.disamonth.2020.101043
7. Azari AA, Arabi A. Conjunctivitis: a systematic review. J Ophthalmic Vis Res. 2020;15(3):372-395. doi:10.18502/jovr.v15i3.7456
8. Ting DSJ, Ho CS, Deshmukh R, Said DG, Dua HS. Infectious keratitis: an update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance. Eye (London, England). 2021;35(4):1084-1101. doi:10.1038/s41433-020-01339-3
9. Lee JM, Baek JS. Etiology of epiphora. Korean J Ophthalmol. 2021;35(5): 349-354. doi:10.3341/kjo.2021.0069
10. Woog JJ. The incidence of symptomatic acquired lacrimal outflow obstruction among residents of Olmsted County, Minnesota, 1976-2000 (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc. 2007;105:649-666.
11. Al-Mohtaseb Z, Schachter S, Shen Lee B, Garlich J, Trattler W. The relationship between dry eye disease and digital screen use. Clin Ophthalmol. 2021;15:3811-3820. doi:10.2147/OPTH.S321591
12. Narendra K, Singh SK, Deepa CK, et al. Exploring new frontiers in dry eye disease: treatments, mechanisms, and diagnostic innovations a comprehensive review. Aspect Mol Med. 2025;5:100090. doi:10.1016/j.amolm.2025.100090
13. Psychosocial distress and psychological adjustment in patients with ocular loss: a framework analysis | BMC Oral Health | Full Text. Accessed September 18, 2025. https://bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-022-02597-1
14. Alam M, Abbas K, Dar GA, Nosaiba, Ahmed K. Nootropic property of punica grantum extract as BDNF4 stimulant for treatment of major depressive disorder. Int Neuropsychiatr Dis J. 2024;21(2):24-35. doi:10.9734/indj/2024/v21i2424
15. Guo Y, Wu D, Jin Y, Tian Y, Li X. Prevalence and risk factors for depression and anxiety in patients with nasolacrimal duct obstruction. Front Psychiatry. 2023;14:1174404. doi:10.3389/fpsyt.2023.1174404
16. Warees A, Saeed A, Hasan W, Ahsan S, Faraz M. Precision gene therapy: a transformative approach to treat age-related macular degeneration (ARMD). Ophthalmol Res Int J. 2025;20(4):1-15. doi:10.9734/or/2025/v20i4461
17. Isorauhimbine and Vinburnine as Novel 5-HT2A Receptor Antagonists from Rauwolfia serpentina for the Treatment of Insomnia: an In Silico Investigation. Accessed September 18, 2025. https://www.chronobiology inmedicine.org/journal/view.php?number=190
18. Liu Z, Sun S, Sun X, Wu Y, Huang Y. Differences of anxiety and depression in dry eye disease patients according to age groups. Front Psychiatry. 2022;13:930714. doi:10.3389/fpsyt.2022.930714
19. Schulz CB, Rainsbury P, Hoffman JJ, et al. The watery eye quality of life (WEQOL) questionnaire: a patient-reported outcome measure for surgically amenable epiphora. Eye (Lond). 2022;36(7):1468-1475. doi:10. 1038/s41433-021-01674-z
20. Jafari A, Simmonds JC, Mitchell MB, et al. A new patient-reported outcomes measure for surgically treated epiphora: Tearing Assessment and Rating Scale-12 (TEARS-12). Am J Rhinol Allergy. 2024;38(4):211-217. doi:10.1177/19458924241241871
21. Pimentel de Figueiredo AR, Almeida Dantas R, Piffaretti JM, Haefliger IO. Treatment of epiphora in connection with endolacrimal surgery using trephines: new and overview data. Klin Monbl Augenheilkd. 2013;230(4):385-389. doi:10.1055/s-0032-1328380
22. Schargus M, Geerling G. Diagnosis and treatment of the watering eye. HNO. 2017;65(1):69-84. doi:10.1007/s00106-016-0286-8
23. Bohman E, Wyon M, Lundström M, Dafgård Kopp E. A comparison between patients with epiphora and cataract of the activity limitations they experience in daily life due to their visual disability. Acta Ophthalmol. 2018;96(1):77-80. doi:10.1111/aos.13447
24. Shin JH, Kim YD, Woo KI; Korean Society of Ophthalmic Plastic and Reconstructive Surgery (KSOPRS). Impact of epiphora on vision-related quality of life. BMC Ophthalmol. 2015;15:6. doi:10.1186/1471-2415-15-6
25. Schulz CB, Rainsbury P, Hoffman JJ, et al. The watery eye quality of life (WEQOL) questionnaire: a patient-reported outcome measure for surgically amenable epiphora. Eye (Lond). 2022;36(7):1468-1475. doi:10. 1038/s41433-021-01674-z
26. Usmani E, Shapira Y, Selva D. Functional epiphora: an under-reported entity. Int Ophthalmol. 2023;43(8):2687-2693. doi:10.1007/s10792-023-02668-4
27. Koh S, Inoue Y, Ochi S, Takai Y, Maeda N, Nishida K. Quality of vision in eyes with epiphora undergoing lacrimal passage intubation. Am J Ophthalmol. 2017;181:71-78. doi:10.1016/j.ajo.2017.06.022
</ol>
<p>